Skip to main content

Blog

This Year, I Am Grateful For Our Journey Together

...

Equitable Access in Clinical Trials—A Call for Action and Collaboration

...

WATCH: RGX-202 – AFFINITY DUCHENNE Pivotal Program and Functional Data (Webinar Recording)

...

PPMD Culminates 30th Anniversary with Celebratory “Investing in Every Future” Event

...

REGENXBIO Initiates Pivotal Phase of AFFINITY DUCHENNE® Trial of RGX-202 Gene Therapy, Reports Positive Functional Data

...

REGENXBIO Initiates Pivotal Phase of AFFINITY DUCHENNE® Trial of RGX-202 Gene Therapy, Reports Positive Functional Data

...

Calling All Adults with Duchenne & Becker: Join the 2025 PPMD Adult Advisory Committee

...

REGENXBIO Shares Updates on Phase I/II AFFINITY DUCHENNE® trial of RGX-202

...

Solid Biosciences Shares Updates on INSPIRE DUCHENNE Clinical Trial of SGT-003

...

Sarepta Announces Discontinuation of SRP-5051 Development for Duchenne

...